Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics |
Hospital for Sick Children / Vijay Ramaswamy, MD |
Young Investigator Grants |
2014 |
Ontario |
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients |
Vanderbilt University Medical Center / Rachael Schulte, MD |
Young Investigator Grants |
2018 |
Tennessee |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance |
Washington University / Nicole Brossier, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
MicroRNAs 100 and 125b in Ewing sarcoma |
University of Colorado Denver / Paul Jedlicka |
Young Investigator Grants |
2010 |
Colorado |
A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Madeline Hayes, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |